Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 787 of 6351
-
Can a Blood-Derived injection ease thumb arthritis pain?
Disease control OngoingThis is a randomized double-blinded randomized comparison between injection of platelet rich plasma (PRP) and placebo for thumb basale osteoarthritis.
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a kidney drug be the next breakthrough for heart failure?
Disease control Recruiting nowFinerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mildly reduced or preserved left ventricular ejection fraction.
Phase 3 • Sponsor: Colorado Prevention Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New combo shot CagriSema takes on tirzepatide in diabetes showdown
Disease control CompletedThis study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a medicine called tirzepatide that doctors may…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New obesity drug shows promise in japanese trial
Disease control CompletedThis study is open to adults who are at least 18 years old and have * a body mass index (BMI) of 35 kg/m² or more and at least one health problem related to their weight, or * a BMI of 27 kg/m² or more and at least two health problems related to their weight. People who have ei…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Immunotherapy plus chemo shows promise for bile duct cancer in early trial
Disease control Recruiting nowTo find out if adding pembrolizumab to standard of care chemotherapy drugs (cisplatin and gemcitabine) will improve long-term response of intrahepatic cholangiocarcinoma after surgery, compared to treatment with surgery and standard chemotherapy alone.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New scan could spot hidden cancers faster and more accurately
Diagnosis Recruiting nowThe goal of this clinical trial is to learn if \[68Ga\]Ga-FAPI-46 Total Body PET/CT can diagnose patients suffering from gastroesophageal cancer and pancreatic cancer. The investigators hope that \[68Ga\]Ga-FAPI-46 Total Body PET/CT can improve staging and treatment evaluation fo…
Phase 2 • Sponsor: Barbara Malene Fischer • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Mothers and daughters join forces to fight HPV in nigeria
Prevention CompletedIn the current pilot study, Actions for Collaborative Community-Engaged Strategies for HPV (ACCESS-HPV), investigators will use participatory crowdsourcing methods to drive HPV prevention among mother-daughter dyads. Crowdsourcing open calls will allow us to identify locally rele…
Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Liver transplant offers new hope for incurable bile duct cancer
Disease control Recruiting nowLITALHICA is a prospective non-randomized study aimed at exploring the outcome of liver transplantation in selected patients with unresectable perihilar cholangiocarcinoma (pCCA) after treatment with standard of care chemotherapy, in terms of overall survival and quality of life.…
Sponsor: Azienda Sanitaria Ospedaliera • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Blood test revolution: pinpointing the cause of swelling attacks
Diagnosis Recruiting nowThis clinical trial aims to evaluate and compare novel and commercially available diagnostic assays through blood tests for the differential diagnosis and comprehensive assessment of patients experiencing recurrent angioedema attacks, including both urticarial and non-urticarial …
Sponsor: Foundation For Rare Disease Research • Aim: Diagnosis
Last updated Aug 26, 2026 00:00 UTC
-
Can a phone app nudge people toward exercise and slow Parkinson's?
Prevention Recruiting nowThe goal of this clinical trial is to investigate the feasibility if a remotely administered smartphone app can increase the volume and intensity of physical activity in daily life in patients with isolated Rapid Eye Movement (REM) sleep behaviour disorder over a long period of t…
Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Could an egg powder boost survival in brain cancer?
Disease control Recruiting nowThis is a randomised, double blinded and multiple center , Phase 2 study in patients with newly diagnosed glioblastoma. Participants will receive an egg powder enriched for antisecretory factor (AF), Salovum, or a placebo egg powder daily from 2 days before concomitant radio-chem…
Phase 2/3 • Sponsor: Peter Siesjö • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New vaccine aims to protect african children from deadly salmonella
Vaccine CompletedThe purpose of this study is to evaluate the safety, reactogenicity, and immune response of the GlaxoSmithKline (GSK) Vaccines Institute for Global Health (GVGH) invasive nontyphoidal Salmonella-generalized modules for membrane antigens (iNTS-GMMA) candidate vaccine against S. Ty…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Sep 04, 2026 00:00 UTC
-
Can a diabetes drug shrink fatty liver in thyroid patients?
Disease control OngoingNon-alcoholic fatty liver disease (NAFLD) is a global epidemic with a prevalence of 25-40%.Primary Hypothyroidism is one of Endocrinopathies who are at risk of developing NAFLD/NASH and estimated prevalence of Primary Hypothyroidism in NAFLD patients is 10-15 %.Though First line …
Early phase 1 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Thigh muscle transplant may bring back elbow bending after nerve damage
Disease control Completed* Study Overview This single-arm prospective clinical trial evaluates the efficacy of gracilis free functional muscle transfer (FFMT) for restoring elbow flexion in patients with late-presenting brachial plexus injuries (≥12 months post-injury) or failed prior reconstructive surg…
Sponsor: Aswan University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Texting to stop HIV: 5,000 teens join landmark prevention study
Prevention Recruiting nowSHAG is a text messaging-based HIV prevention program designed for cisgender sexual minority boys and men 13-20 years of age across the United States. Investigators will test it against a control group that receives messages about healthy lifestyle.
Sponsor: Center for Innovative Public Health Research • Aim: Prevention
Last updated Jul 11, 2026 00:00 UTC
-
Can a Patient's own blood components outperform daily ED pills?
Disease control CompletedErectile dysfunction (ED) is defined as the inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance.Erectile dysfunction (ED) is one of the commonest disorders in adult males and affects 12-19% of men of reproductive age.Erectile dysfunc…
Phase 2/3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Virtual heart model aims to predict and prevent HCM complications
Knowledge-focused OngoingThe goal of SMASH-HCM is to develop a digital twin or virtual model of the heart and vascular system with sympathetic nerve control that integrates multi-scale and multi-organ spatiotemporal biophysical data from a multitude of sources. SMASH-HCM's digital twin powered platform w…
Sponsor: Tampere University • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Custom mRNA vaccine takes on rare endocrine cancers
Disease control Recruiting nowTreatment of advanced endocrine tumors, including adrenal corticocarcnioma (ACC), medullary thyroid carcinoma (MTC), thymic neuroendocrine tumor and pancreatic neuroendocrine tumor is challenging. Previous genomic profiling studies showed they presented a number of somatic mutati…
Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Zapping the brain with slow electrical waves may cut seizures in drug-resistant epilepsy
Disease control CompletedThis pilot study evaluated whether a type of non-invasive brain stimulation called slow-oscillatory transcranial direct current stimulation (so-tDCS) can reduce seizure frequency in patients with drug-resistant focal epilepsy. Ten patients received 14 days of so-tDCS (2 mA, 1 Hz)…
Sponsor: The First Hospital of Hebei Medical University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New antibody aims to calm ankylosing spondylitis
Disease control CompletedThis is a multicentre, randomized, double-blind, parallel, placebo-controlled Phase II clinical study of 261 adults with active ankylosing spondylitis to evaluate the efficacy and safety of JS005 in the treatment of active ankylosing spondylitis.
Phase 2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC